KIN - Kindred Biosciences - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $3.08. This is a potential upside of $3.08 (0%) from yesterday's end of day stock price of $0.

Kindred Biosciences's activity chart (see below) currently has 39 price targets and 33 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50.3% with an average time for these price targets to be met of 183 days.

Most recent stock forecast was given by BEN HAYNOR from ALLIANCE GLOBAL PARTNERS on 22-Aug-2021. First documented stock forecast 16-Nov-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$15.25

4 years 2 months 3 days ago
(22-Aug-2021)

2/4 (50%)

$10.95 (254.65%)

332

Hold

4 years 4 months 9 days ago
(16-Jun-2021)

2/4 (50%)

$4.96 (35.33%)

30

Hold

$9.25

$11

4 years 4 months 10 days ago
(15-Jun-2021)

1/5 (20%)

$0.02 (0.22%)

69

Hold

$9.25

4 years 4 months 10 days ago
(15-Jun-2021)

1/2 (50%)

$0.02 (0.22%)

69

Buy

$9

$-0.25 (-2.70%)

$13

4 years 5 months 14 days ago
(11-May-2021)

1/3 (33.33%)

$4.7 (109.30%)

35

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KIN (Kindred Biosciences) average time for price targets to be met?

On average it took 183 days on average for the stock forecasts to be realized with a an average price target met ratio 50.3

Which analyst has the current highest performing score on KIN (Kindred Biosciences) with a proven track record?

ALEX ARFAEI

Which analyst has the most public recommendations on KIN (Kindred Biosciences)?

Alex Arfaei has 5 price targets and 6 ratings on KIN

Which analyst is the currently most bullish on KIN (Kindred Biosciences)?

Brooks O'neil with highest potential upside - $2.75

Which analyst is the currently most reserved on KIN (Kindred Biosciences)?

Alex Arfaei with lowest potential downside - -$4.25

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?